Metaanalysis of BRAF mutations and clinicopathologic characteristics in primary melanoma

Journal of the American Academy of Dermatology

Volumn 72, Issue 6, 2015, Pages 1036-1046.e2

  Kim, Soo Young ^a   Kim, Soo Nyung ^a   Hahn, Hyung Jin ^a   Lee, Yang Won ^a,b   Choe, Yong Beom ^a,b   Ahn, Kyu Joong ^a,b  

^a Konkuk University School of Medicine   (South Korea)

^b Konkuk University   (South Korea)

Author keywords

Asians; BRAF mutation; melanoma; metaanalysis; race; systematic review

Indexed keywords

B RAF KINASE; BRAF PROTEIN, HUMAN;

AGE; ARTICLE; ASIAN; CANCER STAGING; CAUCASIAN; CLINICAL FEATURE; CUTANEOUS MELANOMA; GENE MUTATION; HISTOLOGY; HUMAN; MUTATION RATE; PRIMARY MELANOMA; PRIMARY TUMOR; PRIORITY JOURNAL; RACE DIFFERENCE; RADIATION EXPOSURE; SEX; SKINFOLD THICKNESS; SYSTEMATIC REVIEW; ULTRAVIOLET RADIATION; ADULT; ADVERSE EFFECTS; AGE DISTRIBUTION; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION; GENETICS; INCIDENCE; MALE; MELANOMA; META ANALYSIS; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; SEX RATIO; SKIN NEOPLASMS; SOUTH KOREA; SURVIVAL; TUMOR INVASION; VERY ELDERLY;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; MUTATION; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROTO-ONCOGENE PROTEINS B-RAF; REPUBLIC OF KOREA; SEX DISTRIBUTION; SKIN NEOPLASMS; SURVIVAL ANALYSIS; ULTRAVIOLET RAYS;

EID: 84929652884     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2015.02.1113     Document Type: Article

References (57)

1. A.J. Miller, and M.C. Mihm Jr. Melanoma N Engl J Med 355 2006 51 65
2. P.B. Chapman, A. Hauschild, and C. Robert Improved survival with vemurafenib in melanoma with BRAF V600E mutation N Engl J Med 364 2011 2507 2516
3. J.A. Sosman, K.B. Kim, and L. Schuchter Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib N Engl J Med 366 2012 707 714
4. A. Hauschild, J.J. Grob, and L.V. Demidov Dabrafenib in BRAF-mutated metastatic melanoma: a multicenter, open-label, phase 3 randomised controlled trial Lancet 380 2012 358 365
5. H. Davies, G.R. Bignell, and C. Cox Mutations of the BRAF gene in human cancer Nature 417 2002 949 954
6. Y. Sasaki, C. Niu, and R. Makino BRAF point mutations in primary melanoma show different prevalences by subtype J Invest Dermatol 123 2004 177 183
7. J. Lang, and R.M. MacKie Prevalence of exon 15 BRAF mutations in primary melanoma of the superficial spreading, nodular, acral, and lentigo maligna subtypes J Invest Dermatol 125 2005 575 579
8. D.F. Stroup, J.A. Berlin, and S.C. Morton Meta-analysis of observational studies in epidemiology: a proposal for reporting; meta-analysis of observational studies in epidemiology (MOOSE) group JAMA 283 2000 2008 2012
9. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analysis BMJ 327 2003 557 560
10. M. Egger, G. Smith, and D.G. Altman Systematic reviews in health-care: meta-analysis in context 2nd ed. 2001 BMJ Books London
11. J.P. Higgins, and S.G. Thompson Quantifying heterogeneity in a meta-analysis Stat Med 21 2002 1539 1558
12. P. Uribe, Wistuba II, and S. González BRAF mutation: a frequent event in benign, atypical, and malignant melanocytic lesions of the skin Am J Dermatopathol 25 2003 365 370
13. J.L. Maldonado, J. Fridlyand, and H. Patel Determinants of BRAF mutations in primary melanomas J Natl Cancer Inst 95 2003 1878 1890
14. K. Omholt, A. Platz, L. Kanter, U. Ringborg, and J. Hansson NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression Clin Cancer Res 9 2003 6483 6488
15. J. Reifenberger, C.B. Knobbe, and A.A. Sterzinger Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas Int J Cancer 109 2004 377 384
16. M. Shinozaki, A. Fujimoto, D.L. Morton, and D.S. Hoon Incidence of BRAF oncogene mutation and clinical relevance for primary cutaneous melanomas Clin Cancer Res 10 2004 1753 1757
17. N.E. Thomas, A. Alexander, and S.N. Edmiston Tandem BRAF mutations in primary invasive melanomas J Invest Dermatol 122 2004 1245 1250
18. M. Deichmann, M. Thome, A. Benner, and H. Näher B-raf exon 15 mutations are common in primary melanoma resection specimens but not associated with clinical outcome Oncology 66 2004 411 419
19. M. Libra, G. Malaponte, and P.M. Navolanic Analysis of BRAF mutation in primary and metastatic melanoma Cell Cycle 4 2005 1382 1384
20. L.A. Akslen, S. Angelini, and O. Straume BRAF and NRAS mutations are frequent in nodular melanoma but are not associated with tumor cell proliferation or patient survival J Invest Dermatol 125 2005 312 317
21. M. Takata, Y. Goto, and N. Ichii Constitutive activation of the mitogen-activated protein kinase signaling pathway in acral melanomas J Invest Dermatol 125 2005 318 322
22. J.A. Curtin, J. Fridlyand, and T. Kageshita Distinct sets of genetic alterations in melanoma N Engl J Med 353 2005 2135 2147
23. V.K. Goel, A.J. Lazar, C.L. Warneke, M.S. Redston, and F.G. Haluska Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma J Invest Dermatol 126 2006 154 160
24. M. Deichmann, D. Krahl, M. Thome, K. Wüst, J. Hassanzadeh, and B. Helmke The oncogenic B-raf V599E mutation occurs more frequently in melanomas at sun-protected body sites Int J Oncol 29 2006 139 145
25. J.N. Poynter, J.T. Elder, and D.R. Fullen BRAF and NRAS mutations in melanoma and melanocytic nevi Melanoma Res 16 2006 267 273
26. G. Saldanha, L. Potter, P. Daforno, and J.H. Pringle Cutaneous melanoma subtypes show different BRAF and NRAS mutation frequencies Clin Cancer Res 12 2006 4499 4505
27. E. Edlundh-Rose, S. Egyházi, and K. Omholt NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing Melanoma Res 16 2006 471 478
28. W. Liu, J.W. Kelly, and M. Trivett Distinct clinical and pathological features are associated with the BRAF(T1799A(V600E)) mutation in primary melanoma J Invest Dermatol 127 2007 900 905
29. N.E. Thomas, S.N. Edmiston, and A. Alexander Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma Cancer Epidemiol Biomarkers Prev 16 2007 991 997
30. L.A. Akslen, H. Puntervoll, and I.M. Bachmann Mutation analysis of the EGFR-NRAS-BRAF pathway in melanomas from black Africans and other subgroups of cutaneous melanoma Melanoma Res 18 2008 29 35
31. M.C. Fargnoli, K. Pike, and R.M. Pfeiffer MC1R variants increase risk of melanomas harboring BRAF mutations J Invest Dermatol 128 2008 2485 2490
32. A. Viros, J. Fridlyand, and J. Bauer Improving melanoma classification by integrating genetic and morphologic features PLoS Med 5 2008 e120
33. C. Beadling, E. Jacobson-Dunlop, and F.S. Hodi KIT gene mutations and copy number in melanoma subtypes Clin Cancer Res 1 14 2008 6821 6828
34. C. Kannengiesser, A. Spatz, and S. Michiels Gene expression signature associated with BRAF mutations in human primary cutaneous melanomas Mol Oncol 1 2008 425 430
35. O.E. Dadzie, S. Yang, A. Emley, M. Keady, J. Bhawan, and M. Mahalingam RAS and RAF mutations in banal melanocytic aggregates contiguous with primary cutaneous melanoma: clues to melanomagenesis Br J Dermatol 160 2009 368 375
36. M. Daniotti, A. Ferrari, and S. Frigerio Cutaneous melanoma in childhood and adolescence shows frequent loss of INK4A and gain of KIT J Invest Dermatol 129 2009 1759 1768
37. P. Uribe, Wistuba II, and S. Gonzalez Allelotyping, microsatellite instability, and BRAF mutation analyses in common and atypical melanocytic nevi and primary cutaneous melanomas Am J Dermatopathol 31 2009 354 363
38. V. Lázár, S. Ecsedi, and A.G. Szöllosi Characterization of candidate gene copy number alterations in the 11q13 region along with BRAF and NRAS mutations in human melanoma Mod Pathol 22 2009 1367 1378
39. E. Hacker, N.K. Hayward, T. Dumenil, M.R. James, and D.C. Whiteman The association between MC1R genotype and BRAF mutation status in cutaneous melanoma: findings from an Australian population J Invest Dermatol 130 2010 241 248
40. S.M. Broekaert, R. Roy, and I. Okamoto Genetic and morphologic features for melanoma classification Pigment Cell Melanoma Res 23 2010 763 770
41. J.A. Ellerhorst, V.R. Greene, and S. Ekmekcioglu Clinical correlates of NRAS and BRAF mutations in primary human melanoma Clin Cancer Res 17 2011 229 235
42. J. Bauer, P. Büttner, and R. Murali BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site Pigment Cell Melanoma Res 24 2011 345 351
43. R.Q. Qi, L. He, and S. Zheng BRAF exon 15 T1799A mutation is common in melanocytic nevi, but less prevalent in cutaneous malignant melanoma, in Chinese Han J Invest Dermatol 131 2011 1129 1138
44. B. Devitt, W. Liu, and R. Salemi Clinical outcome and pathological features associated with NRAS mutation in cutaneous melanoma Pigment Cell Melanoma Res 24 2011 666 672
45. L. Si, Y. Kong, and X. Xu Prevalence of BRAF V600E mutation in Chinese melanoma patients: large scale analysis of BRAF and NRAS mutations in a 432-case cohort Eur J Cancer 48 2012 94 100
46. A. Ashida, H. Uhara, and Y. Kiniwa Assessment of BRAF and KIT mutations in Japanese melanoma patients J Dermatol Sci 66 2012 240 242
47. H.W. Lee, K.H. Song, and J.W. Hong Frequency of BRAF mutation and clinical relevance for primary melanomas Korean J Pathol 46 2012 246 252
48. S.A. Jin, S.M. Chun, and Y.D. Choi BRAF mutations and KIT aberrations and their clinicopathological correlation in 202 Korean melanomas J Invest Dermatol 133 2013 579 582
49. J.K. Feller, S. Yang, and M. Mahalingam Immunohistochemistry with a mutation-specific monoclonal antibody as a screening tool for the BRAFV600E mutational status in primary cutaneous malignant melanoma Mod Pathol 26 2013 414 420
50. E. Hacker, E. Nagore, and L. Cerroni NRAS and BRAF mutations in cutaneous melanoma and the association with MC1R genotype: findings from Spanish and Austrian populations J Invest Dermatol 133 2013 1027 1033
51. W.O. Greaves, S. Verma, and K.P. Patel Frequency and spectrum of BRAF mutations in a retrospective, single-institution study of 1112 cases of melanoma J Mol Diagn 15 2013 220 226
52. H.T. Niu, Q.M. Zhou, and F. Wang Identification of anaplastic lymphoma kinase break points and oncogenic mutation profiles in acral/mucosal melanomas Pigment Cell Melanoma Res 26 2013 646 653
53. D. Massi, P. Pinzani, and L. Simi BRAF and KIT somatic mutations are present in amelanotic melanoma Melanoma Res 23 2013 414 419
54. A. Zebary, K. Omholt, and I. Vassilaki KIT, NRAS, BRAF and PTEN mutations in a sample of Swedish patients with acral lentiginous melanoma J Dermatol Sci 72 2013 284 289
55. J.H. Lee, J.W. Choi, and Y.S. Kim Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis Br J Dermatol 164 2011 776 784
56. A. Kukita, and K. Ishihara Clinical features and distribution of malignant melanoma and pigmented nevi on the soles of the feet in Japan J Invest Dermatol 92 1989 210S 213S
57. H. Rajagopalan, A. Bardelli, C. Lengaurer, K.W. Kinzler, B. Vogelstein, and V.E. Velculescu Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status Nature 418 2002 934